Relmada Therapeutics Inc (STU:4E2)
€ 5.65 (0%) Market Cap: 590.95 Mil Enterprise Value: 385.50 Mil PE Ratio: 0 PB Ratio: 3.12 GF Score: 22/100

Relmada Therapeutics Inc (STU:4E2) Transcripts

  • 1